GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan · Delayed Price · Currency is PKR 414.81
+5.05 (1.23%)
At close: Sep 4, 2025
GlaxoSmithKline Pakistan Revenue
GlaxoSmithKline Pakistan had revenue of 14.72B PKR in the quarter ending June 30, 2025, with 11.06% growth. This brings the company's revenue in the last twelve months to 62.62B, up 13.29% year-over-year. In the year 2024, GlaxoSmithKline Pakistan had annual revenue of 61.19B with 23.21% growth.
Revenue (ttm)
62.62B
Revenue Growth
+13.29%
P/S Ratio
2.11
Revenue / Employee
36.83M
Employees
1,700
Market Cap
132.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 61.19B | 11.53B | 23.21% |
| Dec 31, 2023 | 49.66B | 7.82B | 18.69% |
| Dec 31, 2022 | 41.84B | 5.18B | 14.13% |
| Dec 31, 2021 | 36.66B | 1.57B | 4.48% |
| Dec 31, 2020 | 35.09B | -1.49B | -4.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 72.39B |
| Highnoon Laboratories | 25.78B |
| The Searle Company | 29.12B |
| AGP Limited | 26.27B |
| Shifa International Hospitals | 26.63B |
| Citi Pharma | 12.97B |
| Ferozsons Laboratories | 18.16B |
| Macter International | 8.48B |